---
title: "Process and Impact Evaluation"
ocid: "ocds-h6vhtk-03eb5f"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-03eb5f"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-03eb5f.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-03eb5f.json"
source: "Find A Tender Service"
current_stage: "Tender"
buyer: "GENOMICS ENGLAND"
published: "2023-07-28"
---

# Process and Impact Evaluation

Buyer: GENOMICS ENGLAND  
Current stage: Tender  
OCID: ocds-h6vhtk-03eb5f

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-03eb5f)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-03eb5f.json)

## Summary

The public procurement contracting process is currently in the tender stage and is being conducted by Genomics England. The title of the procurement is "Process and Impact Evaluation" under the industry category of research consultancy services. Genomics England's Generation Study aims to explore offering whole genome sequencing to newborns to accelerate diagnosis for rare genetic conditions. The procurement deadline for submission of bids is September 8, 2023, with a contract duration of 540 days for the evaluation work.

This tender opportunity by Genomics England is ideal for organisations specialising in implementation science, behavioural science, health informatics, and health economics. Businesses interested in evaluating the acceptability, feasibility, and impact of whole genome sequencing on newborns and the NHS stakeholders should consider bidding. The procurement process offers a chance for companies to contribute to groundbreaking research in genomic medicine and healthcare innovation, aligning with the UK's focus on advancing healthcare technologies and treatments.

## Notice

Genomics England's Generation Study aims to explore the benefits, challenges, and practicalities of offering whole genome sequencing to newborns, to accelerate diagnosis and access to treatment for rare genetic conditions. The programme funding was confirmed on 13 December 2022 with PS105 million of funding to support it. Should it prove beneficial for participants and the wider health service, the study could pave the way for what would be the world's first national newborn screening programme to incorporate whole genome sequencing. The outcome for this project is for Genomics England to work in partnership with an organisation or group of organisations with the specific expertise to deliver the Generation Study evaluation. The Generation Study will: 1. evaluate the scientific and clinical utility and validity, operational feasibility, and impact on the NHS of using Whole Genome Sequencing to screen for a large number of childhood-onset rare genetic conditions and provide ongoing patient support 2. understand how, with consent, newborns' genomic and health data could be used for research to enable new diagnostic discoveries and treatments to be developed 3. explore the potential risks, benefits, and broader implications of storing an individual's genome over their lifetime (e.g., potential for preventative steps, personalised risk-based screening in later life etc.) Please note that this tender seeks a partner to evaluate the first of these three aims only.

### Lot Information

Lot 1

Two key components for which we require specific expertise in implementation science, behavioural science, health informatics and health economics are: * Process Evaluation - will address research questions focusing specifically on whether the programme is acceptable and feasible. It will assess study delivery and processes to inform decision making for a possible future clinical service. * Impact Evaluation - will address possible benefits and harms to: o Stakeholders - including participants, Health Care professionals, and the public o The System - including impact on existing newborn screening programmes and the impact on WGS for other patients as well as understanding comparative costs on the health care system. o Experiences and Attitudes - including participants, the public and 3rd sector organisations. Genomics England will act as sponsor for the Generation Study and associated evaluation work. Genomics England is ultimately accountable for the research of which this evaluation forms part. The successful Tenderer will be responsible for design and delivery of all research related activities pursuant to the bid, including but not limited to the delivery of documents for the HRA and any other relevant regulatory bodies (where necessary). Additional information: Interested parties should register with Genomics England's e-tendering portal https://genomicsengland.bravosolution.co.uk and search for project_857 to access all relevant documentation.

Renewal: An extension option of up to 12 months will be available for this contract

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/022031-2023 |
| Notice type | Tender Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Not specified |
| All stages | Tender |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 28 Jul 2023 |
| Submission deadline | 8 Sep 2023 |
| Future notice date | Not specified |
| Award date | Not specified |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Active |
| Lots status | Active |
| Awards status | Not specified |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | GENOMICS ENGLAND |
| Locality | LONDON |
| Post town | East London |
| Postcode | E14 5AB |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI4 Inner London - East |
| ITL 3 | TLI42 Tower Hamlets |
| Local authority | Tower Hamlets |
| Electoral ward | Canary Wharf |
| Westminster constituency | Poplar and Limehouse |
| Delivery location | TLI London |

## CPV Codes

### Divisions

- 73 - Research and development services and related consultancy services

### Codes

- 73000000 - Research and development services and related consultancy services
- 73210000 - Research consultancy services

## Release History

- 28 Jul 2023 at 14:15 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/022031-2023

## Notice URLs

- http://www.genomicsengland.co.uk
- https://genomicsengland.bravosolution.co.uk

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-03eb5f. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-03eb5f.json.
